Biotech and Money London 2016 Partners



Lead Partner

At EY, we are committed to building a better working world — with increased trust and confidence in business, sustainable growth, development of talent in all its forms, and greater collaboration.

We want to build a better working world through our own actions and by engaging with like-minded organizations and individuals. This is our purpose — and why we exist as an organization.

We want to use our global reach and scale to convene the conversation about the challenges facing economies and the capital markets. When business works better, the world works better.

Platinum Partner

Lilly makes medicines that help people live longer, healthier, more active lives. Founded by Eli Lilly in 1876, we are now the 10th largest pharmaceutical company in the world. We have steadfastly remained independent, but not isolated. Across the globe, Lilly has developed productive alliances and partnerships that advance our capacity to develop innovative medicines at lower costs. Lilly is consistently ranked as one of the best companies in the world to work for, and generations of Lilly employees have sustained a culture that values excellence, integrity and respect for people.

Lilly has been operating in the UK since 1934 and is proud of its heritage in this country. London was host to our first office outside the United States and was closely followed by the first overseas manufacturing site, which opened in Basingstoke in 1939.


Gold Partners

Covington is an international law firm of over 900 lawyers across 10 offices in Europe, the US and Asia. With one of the largest and most comprehensive life sciences industry groups in the world, Covington represents nearly all of the multinational pharmaceutical companies and the largest biotechnology companies, many emerging, mid-size and specialty pharmaceutical, biotechnology and medical device companies, and investors and other key players in the industry. We have extensive experience advising on deals in the sector, with notable expertise in M&A, capital markets transactions, licensing and other strategic alliances and a broad range of commercial contracts.


Putting integrity and excellence at the heart of everything we do, our breadth of experience means we are a trusted adviser to more than 150 UK listed companies ranging from FTSE 100 to mid and small-cap.

Our clients operate in a wide range of industry sectors and in multiple geographies.

As a corporate and institutional stockbroker and investment bank with deep knowledge of the London markets, we offer our clients a tailored, integrated service that is relationship led and outcomes driven.


Nasdaq offers capital raising solutions to more than 3,500 companies around the globe representing more than $9.1 trillion in total market value.

Nasdaq is dedicated to our global network of listed companies through our deep partnerships, unmatched accountability and commitment to the equities market.

Nasdaq includes both U.S. and European listing services businesses. We offer capital raising solutions to over 3,300 companies around the globe representing over $8.0 trillion in total market value (as of December 31, 2013). We operate a variety of listing platforms around the world to provide multiple global capital raising solutions for private and public companies. Our main listing markets are The Nasdaq Stock Market and the exchanges that comprise Nasdaq Nordic and Nasdaq Baltic. We offer a consolidated global listing application to companies to enable them to apply for listing on The Nasdaq Stock Market and the exchanges that comprise Nasdaq Nordic and Nasdaq Baltic, as well as others.

Silver Partners

CMS is a top 10 global law firm and the largest law firm in Europe.  CMS has 59 offices in 33 countries.  Its leading international Lifesciences group brings together a wealth of experience, knowledge and understanding.  High quality advice is delivered from 200 dedicated lawyers across CMS, with over 50 lawyers based in the UK. A number of CMS lawyers are recognised experts in their field and work alongside other leaders in the sector, such as scientists and academics.  Many CMS partners are active members of key industry bodies shaping the legal framework in which its clients operate.

Novasecta is a specialist management consulting firm for biotechnology, pharmaceutical and medical product companies. We help our clients to achieve significant performance improvement and sustainable growth by working with their leaders and teams to develop excellent strategies, capabilities and partnerships.

Novasecta also has a unique set of industry networks, for example we hold regular invitation-only private meetings for senior pharmaceutical company executives to discuss important management and business issues with us and their peers.

JAG Shaw Baker is a law firm dedicated to advising entrepreneurs, companies and investors in high-growth industries.

We represent many of the leading venture capital funds active in Europe and the continent’s most exciting emerging companies, structuring equity, debt and hybrid investments often involving several institutional investors and angels.

Venture capital is a core focus of our practice, and our clients benefit from our extensive network of contacts in the industry. Sectors of particular interest include technology, life sciences and cleantech, and our lawyers are recognised and ranked as leading practitioners in these fields.

With strategically placed offices in the South of England, membership of Kreston International and a global network of independent accountants and business advisers, James Cowper Kreston is ideally placed to provide informed local, national and international advice.

An integrated approach lies at the very heart of our business ethos. We consider all the angles when it comes to providing the widest levels of help, service and support for our clients, and apply the same approach to our people. We believe that a constructive work environment ultimately benefits everyone involved, including you.

Whatever your accounting or business advisory needs, our specialist teams work together on your behalf, placing a high value on sound communication. We understand the factors helping and hindering your immediate and long-term aspirations, and our shared vision is to help you succeed.


As a leading European patent and trade mark attorney firm, Gill Jennings & Every LLP can help you turn your innovations, brands and designs into commercial success.

We understand the importance of intellectual property to your business and by providing clear, creative and expert advice we can assist you in protecting, exploiting and managing your IP assets to maximise their value.

We are consistently recognised by the leading UK legal directories, Chambers, Legal 500 and Managing Intellectual Property, a testament to the quality of our advice and the valued role we play in supporting our clients.

RBC Capital Markets’ Healthcare Investment Banking Group provides its clients with a complete suite of global investment banking products, specialising in Pharmaceuticals and Medical Technology with a core focus on serving emerging small and mid-cap companies. Our team is led by senior-level bankers who possess significant healthcare and capital markets experience.

Our Healthcare Research Group represents a diverse and experienced team of equity professionals, who provide perspective on all major healthcare sectors throughout Europe and North America. Led by (9) analysts, we provide comprehensive coverage on over 120 healthcare companies across eight major sub-sectors.

Since January 2015, RBC has acted as advisor and / or joint bookrunner on 67 healthcare transactions with an aggregate value of $55bn. Our industry knowledge, combined with outstanding client service and execution, has resulted in recurring transactions for our clients as they successfully migrate through each stage of growth.

WilmerHale offers unparalleled legal representation across a comprehensive range of practice areas that are critical to the success of our clients. We practice at the very top of the legal profession and offer a cutting-edge blend of capabilities that enables us to handle deals and cases of any size and complexity. Today, businesses face greater scrutiny and more “bet the company” issues than ever before. With a practice unsurpassed in depth and scope by any other major firm, we have the ability to anticipate obstacles, seize opportunities and get the case resolved or the deal done—and the experience and know-how to prevent it from being undone.

Associate Partners

Arthur J. Gallagher is one of the world’s leading commercial insurance brokers for the life sciences sector.

We operate in 27 countries and have over 20,000 staff worldwide. In the UK, we have 70 offices covering all areas of the country.

Whether you’re a start-up or a multinational, whether you’re operating in the UK or overseas, we help to prepare a range of bespoke insurance covers to meet your needs. Our capability, commitment and professional connections enable us to rationalise your risk, innovatively and cost effectively and deliver bespoke risk transfer programmes that may include:

Directors’ & Officers’ Liability | Clinical Trials Liability | Products and Services Liability | Property coverage, premises based or in Transit | Income and Unproductive R&D Expenditure Protection | Supply Chain risks | Defence and/or Pursuit of Intellectual Property infringement | Professional Indemnity

For more information, please contact David Briggs on +44 (0)207 234 4954 or +44 (0)7557 284714 or by email: [email protected]

Allergy Therapeutics provides information to healthcare professionals about the prevention, diagnosis and treatment of allergic conditions with a special focus on allergy vaccination (also known as specific immunotherapy or desensitisation therapy). Allergy vaccination is a successful treatment that deals with the underlying cause of allergies and not just the symptoms! Allergy Therapeutics has a long-term commitment to the development of innovative therapies for allergy treatment and allergy prevention.

BarclaysWith over 325 years of history and expertise in banking, Barclays moves, lends, invests and protects money for 48 million customers and clients worldwide.

Sunergos Innovations is a commercialisation catalyst that transforms innovation & disruptive IP into real returns for entrepreneurs & our partners.

Cancer Research Technology develops and commercialises exciting new discoveries in cancer research. We’re the meeting point between academia and industry. Our deep understanding of both perspectives enables us to translate promising research into commercial propositions to deliver patient benefit and commercial value that will support further cancer research.

Coulter Partners is a retained executive search consultancy exclusively focussed on Life Sciences. Founded by Bianca Coulter in 2003, we combine access to our global network of talent with meticulous contextual research to locate and deliver the best candidates available for assignments in every functional area of the Life Science sector. Our diverse, multi lingual team of consultants combines PhD level scientific understanding with deep sector experience. Our clients range from early stage, venture backed businesses to Global Pharmaceutical companies.

We serve our clients globally from our locations in London (UK), Cambridge (Massachusetts), Princeton (New Jersey) and Nyon (Switzerland).

Evgen Pharma is a clinical stage drug development company focused on cancer and neurological disease. Our pipeline is based on our proprietary Sulforadex® technology, and includes a number of synthetic, stabilised analogues of the naturally occurring compound sulforaphane. Many peer-reviewed scientific papers have identified the medical potential of sulforaphane in multiple indications. Our objective is to use our Sulforadex® technology to turn this scientific promise into commercially successful products, addressing important clinical needs.


Horizon is the leading life science company supplying research tools to organisations engaged in genomics research and the development of personalised medicines. The Company is a trusted supplier of genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. Horizon aspires to provide science-driven research solutions that lead to the advancement in the understanding of the genetic basis of disease and the delivery of better healthcare outcomes for patients.


Imperial Innovations is focused on commercialising leading UK academic research sourced from the ‘golden triangle’ formed between Cambridge, Oxford and London. Imperial Innovations is a technology commercialisation company that combines the activities of technology transfer, intellectual property protection and licensing, company incubation, and investment. Innovations is focused on commercialising the most promising UK academic research across a broad range of technology sectors, and has developed particular expertise in: therapeutics, medtech, engineering and materials and information communication technology.

Biotech companies face a unique set of challenges. In IP development stages, Biotechs consume vast amounts of capital, so early investor trust is crucial. As the IP moves to reality and approaches the market, IPO and finally M&A activities become the focus; here again, trust is the key to success – in security of the IP, the value of the offering, and the solidity of the company. Intralinks has built a reputation of trust in the Biotech community with a history of providing secure spaces and transactional tools for raising start-up capital; for keeping assets valuable and investor-ready; for taking companies public; and for exchanging critical, sensitive M&A information. Intralinks helps build Biotechs by protecting their most valuable assets along every step of the journey. We stand behind Biotechs, so their ideas can move forward.

 NetScientific’s mission is to build a transatlantic biomedical and healthcare group funding and developing technologies that offer transformative benefits to people’s lives and society.

NetScientific funds, develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in USA and Europe with a primary focus on Digital health, Diagnostics and Therapeutics. These represent highly attractive growth markets where breakthrough technology solutions are in high demand.

NetScientific is an active investor providing extensive management support. This can involve the senior management team initially taking leadership roles in companies and building dedicated management teams as the companies develop and grow.

Skyepharma is an expert drug delivery company. We combine proven scientific expertise with validated proprietary drug delivery technologies to develop innovative oral and inhalation pharmaceutical products.

Over many years we have partnered with a wide range of companies, from big pharma such as GlaxoSmithKline, Novartis, Sanofi, Janssen and Roche, to medium-sized pharmaceutical companies like Mundipharma and Kyorin, and smaller specialty pharmaceutical companies. We use our know-how and capabilities, and where appropriate, apply Skyepharma’s proprietary drug delivery technologies to the development of new formulations of existing products as well as new chemical entities, in order to provide clinical benefits to patients.

 Redx Pharma is a drug discovery and development company with a pipeline of proprietary drug candidates targeting significant unmet medical needs in commercially hot areas of infection, immunology and oncology. Redx’s focus on improving existing drugs to create best-in-class new drugs provides opportunities to crystallise value through industry partnerships, with Redx also able to retain a greater economic interest in selected development programs. Redx’s work has already been endorsed by partnerships with global pharmaceutical companies, including AstraZeneca, and the NHS. Formed in 2010, Redx was successfully admitted to AIM (LSE) in March 2015.

BioHub is situated on Birmingham Research Park, a long-standing and successful joint venture between the University of Birmingham and Birmingham City Council. Birmingham Research Park is at the heart of the Edgbaston Medical Quarter, a vibrant and collaborative health science community. This cluster is home to 64% of the City’s healthcare economy including 180 medical organisations, 44 GP clinics and routine care facilities and 80 hospitals and specialist care centres. The BioHub is a brand new, fully serviced biomedical laboratory specifically designed to provide entrepreneurs and innovative start-ups with access to affordable laboratory facilities and equipment.

Strategic Partners


Consilium Strategic Communications is a global leader in providing trusted, healthcare-focused strategic IR and financial PR counsel to corporations, Boards, senior decision makers and executives.

From offices in Europe and USA, Consilium Strategic Communications’ senior team provides cross-border comprehensive financial and corporate healthcare communications advice to some of the world’s most prominent corporations around-the-clock.


We combine strategic and creative thinking to help our clients engage with and influence their key stakeholders.

We understand the power of reputation in a world where reputations are vulnerable.

Connecting financial communications to corporate affairs to public policy and employee engagement with the very best in creativity, story telling and digital capability we help our clients to develop a joined up story.

Truly international in outlook and reach, we are as connected to our clients and their audiences as we are to each other.


Hume Brophy is an international communications firm specialising in Public Relations, Investor Relations, Public Affairs, Corporate and Financial Communications, with operations in Brussels, Dublin, London, Paris and Singapore and an established network of agency partnerships in New York, Hong Kong and across Europe.

Our 80-strong international team is drawn from media, advertising, in-house, agency, marketing, events, investor relations, professional services and industry association backgrounds, offering a blend of skills to meet all communication challenges.


Sciad is a life science and healthcare marketing and communications agency. We help to make our clients’ sales and marketing teams even more successful.

Website design and development | Marketing automation | Content marketing | Social media | Search engine optimisation | Paid search | Public relations | News distribution

The Sciad team is committed to helping companies that use science as the basis for world changing ideas. Call +44 (0)203 773 9580 and ask for Deborah Cockerill or Richard Anderson or email us at [email protected].